Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2018 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Acquired von Willebrand Syndrome and Desmopressin Resistance During Venovenous Extracorporeal Membrane Oxygenation in Patients With COVID-19: A Prospective Observational Study.
Crit Care Med. 2022 Aug 1;50(8):1246-1255. doi: 10.1097/CCM.0000000000005467. Epub 2022 Feb 18.
Crit Care Med. 2022.
PMID: 35234414
Free PMC article.
OBJECTIVES: Although COVID-19 is associated with high von Willebrand factor (vWF) parameters promoting thrombosis, venovenous extracorporeal membrane oxygenation (vvECMO) is associated with the development of acquired von Willebrand syndr …
OBJECTIVES: Although COVID-19 is associated with high von Willebrand factor (vWF) parameters promoting thrombosi …
Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study.
Tiede A, Priesack J, Werwitzke S, Bohlmann K, Oortwijn B, Lenting P, Eisert R, Ganser A, Budde U.
Tiede A, et al.
J Thromb Haemost. 2008 Apr;6(4):569-76. doi: 10.1111/j.1538-7836.2008.02909.x. Epub 2008 Jan 17.
J Thromb Haemost. 2008.
PMID: 18208537
Free article.
BACKGROUND: Diagnosis of acquired von Willebrand syndrome (AVWS) remains challenging. Diagnostic algorithms suggest the use of factor VIII (FVIII:C), von Willebrand factor antigen (VWF:Ag), ristocetin cofactor (VWF:RCo), and …
BACKGROUND: Diagnosis of acquired von Willebrand syndrome (AVWS) remains challenging. Diagnostic algorithms suggest the use of …
Item in Clipboard
Thrombotic microangiopathy in a very young infant with mitral valvuloplasty.
Matsunaga Y, Ishimura M, Nagata H, Uike K, Kinjo T, Ochiai M, Yamamura K, Takada H, Tanoue Y, Hayakawa M, Matsumoto M, Hara T, Ohga S.
Matsunaga Y, et al.
Pediatr Neonatol. 2018 Dec;59(6):595-599. doi: 10.1016/j.pedneo.2018.02.002. Epub 2018 Feb 7.
Pediatr Neonatol. 2018.
PMID: 29523490
Free article.
ADAM metallopeptidase with thrombospondin type 1 motif 13 (ADAMTS13) activity was sustained (64%) with the undetectable inhibitor. Von Willebrand factor (VWF) multimer analyses showed absent high-molecular weight …
ADAM metallopeptidase with thrombospondin type 1 motif 13 (ADAMTS13) activity was sustained (64%) with the undetectable inhibitor. Von …
Item in Clipboard
Cite
Cite